Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Programmed Cell Death 1 Ligand 1(PDL1, PD-L1)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT06888102
What this trial is testing

A Platform Study of Epigenetic Therapy Before Prostatectomy in Men With Prostate Cancer

Who this might be right for
High-risk Prostate Cancer
Edwin Posadas, MD 20
Testing effectiveness (Phase 2)Looking for participantsNCT03556228
What this trial is testing

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

Who this might be right for
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22 more
VM Oncology, LLC 242
Early research (Phase 1)Not Yet RecruitingNCT07348107
What this trial is testing

ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.

Who this might be right for
Advanced Pancreatic Ductal Adenocarcinoma
Daniel Breadner 10
Large-scale testing (Phase 3)Study completedNCT03875092
What this trial is testing

Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)-China Extension Study

Who this might be right for
Non-small Cell Lung Cancer
Merck Sharp & Dohme LLC 125
Not applicableNot Yet RecruitingNCT07171307
What this trial is testing

Treg Effector Function and Th2/Treg Ratio in Allergic Conjunctivitis: Effect of Desensitization Therapy

Who this might be right for
Conjunctivitis, Allergic
Instituto de Oftalmología Fundación Conde de Valenciana 60
Early research (Phase 1)WithdrawnNCT03802747
What this trial is testing

Immunotherapy Combined With Y-90 and SBRT for Colorectal Liver Metastases

Who this might be right for
Colorectal Cancer
University of Colorado, Denver
Testing effectiveness (Phase 2)WithdrawnNCT05145569
What this trial is testing

Antitumor Activity of Neoadjuvant Chemotherapy with or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer

Who this might be right for
Ovarian Cancer
Haider Mahdi
Testing effectiveness (Phase 2)Looking for participantsNCT07689851
What this trial is testing

Chemoradiotherapy and SHR-1701 in Patients With Unresectable Gastric Cancer

Who this might be right for
Gastric Cancer (GC)Gastroesophageal Junction Adenocarcinoma
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 60
Not applicableNot Yet RecruitingNCT07442292
What this trial is testing

PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

Who this might be right for
Lung Cancer (NSCLC)Lung Cancer (SCLC)Melanoma (Skin Cancer)+3 more
Peking University Cancer Hospital & Institute 40
Large-scale testing (Phase 3)Active Not RecruitingNCT05096663
What this trial is testing

Testing the Use of Combination Immunotherapy Treatment (N-803 [ALT-803] Plus Pembrolizumab) Against the Usual Treatment for Advanced Non-small Cell Lung Cancer (A Lung-MAP Treatment Trial)

Who this might be right for
Advanced Lung Non-Small Cell CarcinomaRecurrent Lung Non-Small Cell CarcinomaStage III Lung Cancer AJCC v8+6 more
SWOG Cancer Research Network 82
Testing effectiveness (Phase 2)Study completedNCT03939234
What this trial is testing

Peptide Vaccination With PD-L1 and PD-L2 Peptides in Untreated Chronic Lymphatic Leukemia.

Who this might be right for
Chronic Lymphocytic Leukemia
Lars Møller Pedersen 19
Large-scale testing (Phase 3)Looking for participantsNCT07472153
What this trial is testing

PD-1 (Programmed Death-1) Versus PD-L1 (Programmed Death-ligand 1) Immune Check Point Inhibitors Combined With Chemotherapy, With or Without Bevacizumab, In Patients With Metastatic, Persistent Or Recurrent Cervical Cancer

Who this might be right for
Metastatic Cervical CancerPersistent Cervical CancerRecurrent Cervical Cancer
N.N. Alexandrov National Cancer Centre 120
Large-scale testing (Phase 3)Active Not RecruitingNCT02362594
What this trial is testing

Study of Pembrolizumab (MK-3475) Versus Placebo After Complete Resection of High-Risk Stage III Melanoma (MK-3475-054/1325-MG/KEYNOTE-054)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 1,019
Testing effectiveness (Phase 2)Ended earlyNCT04260802
What this trial is testing

Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic Cancers

Who this might be right for
CancerNeoplasmsMetastatic Cancer+16 more
Ocellaris Pharma, Inc. 73
Not applicableUnknownNCT05692895
What this trial is testing

PDL1 In Primary Colorectal Carcinoma and Its Prognostic Impact

Who this might be right for
PDL1- Colorectal Carcinoma
Sohag University 60
Testing effectiveness (Phase 2)Looking for participantsNCT06869473
What this trial is testing

Cetuximab Plus Platinum and Taxane-based Chemotherapy, Followed by Avelumab and Cetuximab, as First-line Treatment for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) Patients With a PD-L1 Combined Positive Score (CPS)≥1≤19.

Who this might be right for
Head and Neck Squamous Cell Carcinoma (HNSCC)Recurrent Head and Neck CancerMetastatic Head and Neck Cancer
Gruppo Oncologico del Nord-Ovest 67
Not applicableUnknownNCT05028231
What this trial is testing

Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study

Who this might be right for
Esophageal Squamous Cell CarcinomaNeoadjuvant Therapies
Tongji Hospital 46
Early research (Phase 1)Study completedNCT04421352
What this trial is testing

Safety and Tolerability Evaluation of Low-dose Radiation in Combination With CS1001 in Relapsed SCLC Patients

Who this might be right for
Relapsed Small Cell Lung Cancer
CStone Pharmaceuticals 11
Not applicableUnknownNCT06613308
What this trial is testing

Association Between Microbiome and the Efficacy and Safety of PD-1/PD-L1 Blockade in Resectable NSCLC

Who this might be right for
Lung Cancer (NSCLC)
Capital Medical University 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT04837209
What this trial is testing

Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer

Who this might be right for
Breast CancerTriple Negative Breast Cancer
Massachusetts General Hospital 32
Next Page